Neuroleptic withdrawal in schizophrenic patients. A review of the literature.
Gilbert
P L
PL
Department of Psychiatry, University of California-San Diego.
Harris
M J
MJ
McAdams
L A
LA
Jeste
D V
DV
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D004409:Dyskinesia, Drug-Induced / Q000209:etiology / Q000517:prevention & control; D005260:Female; D005500:Follow-Up Studies; D006760:Hospitalization; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D010919:Placebos; D012008:Recurrence; D012044:Regression Analysis; D012559:Schizophrenia / Q000139:chemically induced / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome / Q000209:etiology* / Q000517:prevention & control
D014150:Antipsychotic Agents; D010919:Placebos